Ultragenyx PharmaceuticalRARE
那斯達克 · USD
14.31
-0.57
(-3.83%)
收盤 09/10 03:59 (UTC+8)
盤後
14.31
14.31
(0.00%)
09/10 03:59 (UTC+8)
Ultragenyx PharmaceuticalRARE
14.31
-0.57
(-3.83%)
財務數據
損益表
- 1.09
- 1.47
- 1.39
- 1.65
- 1.39
- 1.67
- 1.60
- 2.07
- 1.36
- 2.14
- -14.57
- 35.09
- -5.12
- 18.20
- -15.52
- 19.74
- -4.24
- 29.60
- -34.39
- 57.35
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 214,000 | 136,000 | 207,279 | 159,721 | 166,788 | 139,292 | 164,877 | 139,494 | 147,026 | 108,833 |
營業成本 | 34,000 | 30,000 | 29,345 | 27,655 | 22,664 | 28,662 | 16,894 | 21,021 | 21,280 | 17,533 |
營業毛利 | 180,000 | 106,000 | 177,934 | 132,066 | 144,124 | 110,630 | 147,983 | 118,473 | 125,746 | 91,300 |
營業費用 | 255,000 | 275,000 | 291,217 | 302,783 | 251,951 | 253,569 | 270,261 | 250,460 | 242,107 | - |
研發費用 | 167,000 | 187,000 | 203,280 | 215,720 | 164,508 | 165,772 | 187,766 | 170,109 | 161,503 | 178,487 |
推銷及管理費用 | 88,000 | 88,000 | 87,937 | 87,063 | 87,443 | 87,797 | 82,495 | 80,351 | 80,604 | 78,160 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -75,000 | -169,000 | -113,283 | -170,717 | -107,827 | -142,939 | -122,278 | -131,987 | -116,361 | -165,347 |
其他收入及費用 | 6,000 | 6,000 | 5,578 | 5,422 | 8,602 | 7,668 | 5,944 | 13,808 | 5,572 | 7,219 |
利息費用 | 22,000 | 21,000 | 19,469 | 14,531 | 14,383 | 14,342 | 15,522 | 15,712 | 15,960 | 15,847 |
稅前純益 | -91,000 | -184,000 | -127,686 | -179,314 | -113,774 | -149,770 | -133,404 | -133,213 | -130,740 | -170,229 |
所得稅 | 1,000 | 1,000 | 870 | 1,130 | 1,257 | 1,310 | -19 | 303 | 858 | 455 |
稅後純益 | -92,000 | -185,000 | -128,556 | -180,444 | -115,031 | -151,080 | -133,385 | -133,516 | -131,598 | -170,684 |
基本每股稅後盈餘(元) | -0.90 | -1.84 | -1.29 | -1.81 | -1.17 | -1.57 | -1.39 | -1.40 | -1.52 | -2.03 |
稀釋每股稅後盈餘(元) | -0.89 | -1.84 | -1.28 | -1.81 | -1.16 | -1.57 | -1.38 | -1.37 | -1.51 | -2.03 |
基本平均股數(千股) | 101900.00 | 100600.00 | 99900.00 | 99771.00 | 98500.00 | 96288.00 | 95681.00 | 95493.00 | 86580.00 | 84286.00 |
稀釋平均股數(千股) | 101900.00 | 100600.00 | 99900.00 | 99771.00 | 98500.00 | 96288.00 | 95681.00 | 95493.00 | 86580.00 | 84286.00 |
還原基本每股稅後盈餘(元) | -0.90 | -1.84 | -1.29 | -1.81 | -1.17 | -1.57 | -1.39 | -1.40 | -1.52 | -2.03 |
還原稀釋每股稅後盈餘(元) | -0.89 | -1.84 | -1.28 | -1.81 | -1.16 | -1.57 | -1.38 | -1.37 | -1.51 | -2.03 |
還原基本平均股數(千股) | 101,900 | 100,600 | 99,900 | 99,771 | 98,500 | 96,288 | 95,681 | 95,493 | 86,580 | 84,286 |
還原稀釋平均股數(千股) | 101,900 | 100,600 | 99,900 | 99,771 | 98,500 | 96,288 | 95,681 | 95,493 | 86,580 | 84,286 |
EBITDA(千元) | -61,000 | -156,000 | -99,948 | -157,052 | -91,562 | -128,171 | -111,609 | -111,859 | -108,865 | -149,293 |